| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Dec 24 | PVLA Palvella Therapeutics | Series F Preferred Stock, par value $0.001 per share | Sale back to company | Dispose D | No | No | 0.01 | 1 | 0.01 | 0 |
| 7 Aug 24 | PVLA Palvella Therapeutics | Series F Preferred Stock, par value $0.001 per share | Buy | Acquire P | No | No | 1 | 1 | 1.00 | 1 |
| 17 Jun 24 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7 | 30,000 | 210.00 k | 30,000 |
| 5 Jun 24 | VYGR Voyager Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.7 | 24,000 | 208.80 k | 24,000 |
| 24 Jan 24 | ORTX Orchard Therapeutics | Ordinary Shares | Sale back to company | Dispose D | No | No | 0 | 44,391 | 0.00 | 0 |
| 24 Jan 24 | ORTX Orchard Therapeutics | Stock Option Ordinary Shares | Sale back to company | Dispose D | No | No | 0.495 | 105,000 | 51.98 k | 0 |
| 24 Jan 24 | ORTX Orchard Therapeutics | Stock Option Ordinary Shares | Sale back to company | Dispose D | No | No | 0.475 | 46,000 | 21.85 k | 0 |
